[Role of polymorphic adhesion molecules in the development of graft-versus-leukemia effect after HLA-matched allogeneic stem cell transplantation]
Related Experiment Video
Updated: Aug 22, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
Shintaro Shiobara1, Hidehiro Sato, Tastuo Furukawa
1Division of Transfusion Medicine, Kanazawa University Hospital.
Abstract:
Mismatches of minor histocompatibility antigens (mHas) between HLA-identical stem cell donors and recipients are known as a major risk factor for graft-versus-host disease (GVHD). We determined the alleles of 5 polymorphic molecules including HA-1 and 4 adhesion molecules in 102 patients who had undergone stem cell transplantation from HLA-identical donors and investigated the association of their mismatches with the relapse rate and incidence of GVHD. We observed relapse rates of 16.1% in patients with at least one or more incompatibilities and 39.4% in patients without incompatibilities (p = 0.018). The respective relapse rates of patients with CD62L, HA-1, CD31 exon 563, CD31 exon 125 and 49b incompatibilities were 6.1%, 14.3%, 11.7%, 20% and 40%. Only patients with CD62L incompatibilities showed a lower relapse rate than patients who received a compatible graft. Since there was no difference between patients with and without incompatibilities as far as the appearance of acute GVHD (> or = 2) was concerned, we conclude that the polymorphic CD62L molecule contributes to graft-versus-leukemia rather than the development of GVHD after HLA-identical stem cell transplantation.
Insights
Minor histocompatibility antigen mismatches in HLA-identical stem cell transplants increase relapse risk. CD62L incompatibilities, however, were linked to lower relapse rates and did not increase graft-versus-host disease (GVHD).
Area of Science:
- Immunogenetics
- Hematopoietic Stem Cell Transplantation
Context:
- Minor histocompatibility antigens (mHas) are crucial in HLA-identical stem cell transplantation.
- Mismatches in mHas are a significant risk factor for graft-versus-host disease (GVHD).
Purpose:
- To investigate the association between mismatches of specific polymorphic molecules (HA-1 and four adhesion molecules) and outcomes in HLA-identical stem cell transplantation.
- To determine if these mismatches impact relapse rates and GVHD incidence.
Summary:
- Relapse rates were significantly lower in patients with at least one mHa incompatibility (16.1%) compared to those without (39.4%).
- Specific incompatibilities, notably CD62L, were associated with reduced relapse rates (6.1%).
- No significant difference in acute GVHD was observed between patients with or without incompatibilities, indicating CD62L promotes graft-versus-leukemia (GVL) rather than GVHD.
Impact:
- Identifies CD62L as a potential target for enhancing GVL effects while mitigating GVHD.
- Provides insights into the immunogenetic factors influencing stem cell transplant outcomes.
- Suggests that careful selection of donors based on mHa profiles, particularly CD62L, could improve patient survival post-transplant.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Regulation of Hematopoietic Stem Cells

